Silymarin, a compound found in milk thistle, has been shown to have significant anti-cancer properties. Research has demonstrated that silymarin can induce programmed cell death (apoptosis) in cancer cells, as well as inhibit the growth and spread of cancer cells. Silymarin has been shown to be effective in treating a variety of cancers, including breast, prostate, colon, and lung cancer, by interfering with multiple cellular signaling pathways involved in cancer development and progression.